Keratin sponge/hydrogel II: Active agent delivery

Textile Research Journal

Volumn 83, Issue 9, 2013, Pages 917-927

  Cardamone, Jeanette M ^a  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

keratin; riboflavin delivery diffusion drug release; sponge hydrogel

Indexed keywords

CONTROLLED DRUG DELIVERY; KERATIN; WOOL; YARN;

BIOTECHNOLOGICAL APPLICATIONS; DRUG RELEASE; FICKIAN DIFFUSION; MICRO-FLUIDIC DEVICES; MOISTURE EQUILIBRIUM; OXIDATION AND REDUCTION; OXIDATIVE SPECIES; SPONGE/HYDROGEL;

TARGETED DRUG DELIVERY;

KERATIN; MATHEMATICAL MODELS; WOOL; YARN;

EID: 84877963592     PISSN: 00405175     EISSN: 17467748     Source Type: Journal    
DOI: 10.1177/0040517512468815     Document Type: Article

References (41)

1. Zhou MI, Smith AM, Das AK, et al. Self- assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials 2009; 30: 2523–2530.
2. Peplow PV, Dias SN and Roddick-Lanzilotta AD. Orthopedic materials derived from keratin. Patent 7,297,342 B2, USA, 2009.
3. Park WH, Ha WS, Ito H, et al. Relationships between antithrombogenicity and surface energy of regenerated silk fibroin films. Fibers Polym 2001; 2: 58–63.
4. Yamauchi K, Maniwa M, Mori T. Cultivation of fibroblast cells on keratin-coated substrata. J Biomater Sci Polym 1998; 9: 259–270.
5. Tachibana A, Furuta Y, Takeshima H, et al. Fabrication of wool keratin sponge scaffolds for long-term cell cultivation. J Biotech 2002; 93: 165–170.
6. Blanchard CR, Timmons SF and Smith RA. Keratin-based hydrogel for biomedical applications and method of production. Patent 2001/0009675 A, USA, 2001.
7. Timmons SF, Blanchard CR and Smith RA. Keratin-based tissue engineering scaffold. Patent 6,432,435 B, USA, 2002.
8. Siller-Jackson AJ, Van Dyke ME, Timmons SF, et al. Keratin-based powders and hydrogel for pharmaceutical applications. Patent 6,544,548 B, USA, 2003.
9. Katoh K, Shibayama M, Tanabe T, et al. Preparation and physiochemical properties of compression-molded keratin films. Biomaterials 2004; 25: 2265–2275.
10. Kelly RJ, Ali MA, Roddick-Lanzilotta AD, et al. Composite materials containing keratin. Patent 7,767,756 B2, USA, 2010.
11. Kelly RJ, Roddick-Lanzilotta AD and Ali MA. Wound care products containing keratin. Patent 7,732,574 B2, USA, 2010.
12. Kelly RJ, Roddick-Lansilotta AD, Rankin DA, et al. Production of biopolymer film, fibre, foam and adhesive materials from soluble S-sulfonated keratin derivatives. Patent 0069541 A, USA, 2009.
13. Kelly RJ, Worth GH, Roddick-Lanzilotta AD, et al. Production of soluble keratin derivatives. Patent 7,148,327 B2, USA, 2006.
14. Tachibana A, Nishikawa Y, Nishino M, et al. Modified keratin sponge: binding of bone morphogenetic protein-2 and osteoblasty differentiation. J Biosci Bioeng 2006; 102: 425–429.
15. Caruso J, Sivas SL, Meyer JL. Straightforward approach for screening silicone gels of varying functionality for use in cosmetic ingredient delivery. J Cosmetic Sci 2008; 59: 368–369.
16. Gueret JL. Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least, one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent. Patent 6,063,398, USA, 2000.
17. Kotzar G, Fraes M, Abel P, et al. Evaluation of MEMS materials of construction for implantable medical devices. Biomaterials 2002; 23: 2737–2750.
18. Morgan L and Millard ML. Medical sponges and wipes with a barrier impermeable to infectious agents. Patent 5,009,652, USA, 1991.
19. Bara I and Mellul M. Cosmetic composition for the make-up of the skin, containing at least one silicone wax and process for its preparation. Patent 5,478,555, USA, 1995.
20. Fujimoto S and Sugiyama M. Method for making a cellular rubber, cellular rubbers obtained by the method, and cosmetic puffs made of the cellular rubber. Patent 5,434, 194, USA, 1995.
21. Martin JC, Kilburn RS, Teague KL, et al. Method of manufacturing a sponge device. Patent 6,852, 258 B1, USA, 2005.
22. Zhang XZ, Yang YY, Chung TS, et al. Preparation and characterization of fast response macroporous poly(n-isopropylacrylamide) hydrogels. Langmuir 2001; 17: 6094–6099.
23. Berry MG, Davies DM. Breast augmentation: Part I – review of the silicone prosthesis. J Plast Reconstructive Aesthetic Surg 2013; 63: 1761–1768.
24. Bajpai SK, Sonkusley J. Dynamic release of riboflavin from a colon-targeted delivery device: an in vitro study. React Funct Polym 2003; 55: 197–210.
25. Noll M and Schulze ZWE. Hair-protective cosmetics. WO 2011000649 (A2), 2011.
26. Weser G and Henke M. Novel agent for treating keratin fibres. WO 2006021350, 2006.
27. Becvar J, Palmer G. The binding of flavin derivatives to the riboflavin-binding protein of egg white. J Biol Chem 1982; 257: 5607–5617.
28. Kamat BP, Seetharamappa J, Melwanki MB. Spectroscopic studies on the interaction of riboflavin with bovine serum albumin. Ind J Biochem Biophys 2004; 41: 173–178.
29. Abd El-Ghaffar MA, Hashem MS, El-Awady MK, et al. pH-sensitive sodium alginate hydrogels for riboflavin controlled release. Carbohydr Polym 2012; 89: 667–675.
30. Patel VR, Amiji MM. pH sensitive swelling and drug-release properties of chitosan-poly(ethylene oxide) semi-penetrating polymer network. In: Hydrogels and biodegradable polymers for bioapplications, ACS Symposium Series 627. Chapter 17, Washington, DC: American Chemical Society, 1996 209–220.
31. Young JF. Humidity control in the laboratory using salt solutions – a review. J Appl Chem 1967; 17: 241–245.
32. Kortesuo P, Ahola M, Kangas M, et al. In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters. Int J Pharm 2001; 221: 107–114.
33. Metcalf RL, Paton RL. A study of riboflavin metabolism in the American roach by fluorescence microscopy. J Cell Comp Physiol 1942; 19: 373–376.
34. Peppas N. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985; 60: 110–111.
35. Patel VR, Amiji MM. Preparation and characterization of freeze-dried chitosan- poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach. Pharm Res 1996; 13: 588–592.
36. Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 25–35.
37. Brannon-Peppas L, Peppas NA. Solute and penetrant diffusion in swellable polymers. IX. The mechanisms of drug release from pH-sensitive swelling-controlled-systems. J Controlled Release 1989; 8: 2667–2674.
38. Peppas NA, Franson NM. The swelling interface number as a criterion for prediction of diffusion solute release mechanisms in swellable polymers. J Polym Sci 1983; 21: 983–997.
39. Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52: 1145–1149.
40. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind Eng Chem 1931; 23: 923–931.
41. Franso NM, Peppas NA. Influence of copolymer composition on non-Fickian water transport through glassy copolymers. J Appl Polym Sci 1983; 28: 1299–1231.